HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sargo Aalto Selected Research

Dopamine D2 Receptors (Dopamine D2 Receptor)

4/2005Increased caudate dopamine D2 receptor availability as a genetic marker for schizophrenia.
11/2004Insular dopamine D2 receptors and novelty seeking personality in Parkinson's disease.
11/2003Altered dopamine D2 receptor binding in atypical facial pain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sargo Aalto Research Topics

Disease

6Parkinson Disease (Parkinson's Disease)
12/2010 - 02/2004
4Alzheimer Disease (Alzheimer's Disease)
10/2009 - 01/2008
3Cognitive Dysfunction
01/2012 - 06/2010
3Dementia (Dementias)
01/2012 - 11/2008
3Schizophrenia (Dementia Praecox)
10/2006 - 04/2005
3Psychotic Disorders (Schizoaffective Disorder)
11/2005 - 12/2002
2Major Depressive Disorder (Major Depressive Disorders)
10/2011 - 01/2008
2Atrophy
12/2010 - 11/2008
1Pain (Aches)
07/2012
1Disease Progression
11/2008
1Cerebral Amyloid Angiopathy (Congophilic Angiopathy)
04/2008
1Familial Cerebral Amyloid Angiopathy
04/2008
1Alcoholism (Alcohol Abuse)
12/2005
1Asperger Syndrome (Asperger's Syndrome)
04/2004
1Facial Pain (Myofacial Pain)
11/2003
1Burning Mouth Syndrome (Syndrome, Burning Mouth)
01/2003
1Hallucinations (Hallucination)
12/2002

Drug/Important Bio-Agent (IBA)

10Dopamine (Intropin)FDA LinkGeneric
10/2011 - 12/2002
62- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA
12/2010 - 01/2008
4RacloprideIBA
10/2011 - 12/2002
4Levodopa (L Dopa)FDA LinkGeneric
05/2009 - 04/2004
3Amyloid beta-PeptidesIBA
12/2010 - 11/2008
3CarbonIBA
10/2008 - 04/2005
3Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
04/2005 - 11/2003
2Amyloid (Amyloid Fibrils)IBA
01/2012 - 04/2008
2Pharmaceutical PreparationsIBA
07/2006 - 04/2004
2KetamineFDA LinkGeneric
11/2005 - 12/2002
2Glutamic Acid (Glutamate)FDA Link
11/2005 - 12/2002
1Opioid Receptors (Opioid Receptor)IBA
07/2012
1Antidepressive Agents (Antidepressants)IBA
10/2011
1Glucose (Dextrose)FDA LinkGeneric
12/2010
1Fluoxetine (Prozac)FDA LinkGeneric
01/2008
1SCH 23390IBA
10/2006
1Dopamine D1 Receptors (Dopamine D1 Receptor)IBA
10/2006
1Antipsychotic Agents (Antipsychotics)IBA
10/2006
1LigandsIBA
10/2006
1Dihydroxyphenylalanine (Dopa)IBA
07/2006
1Narcotic Antagonists (Opioid Antagonists)IBA
12/2005
1nalmefene (Revex)FDA Link
12/2005
1Genetic Markers (Genetic Marker)IBA
04/2005
1FLB 457IBA
11/2004
1Caffeine (No Doz)FDA LinkGeneric
02/2004
1Purinergic P1 Receptor AntagonistsIBA
02/2004
1odapipamIBA
11/2003
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
12/2002
1Phencyclidine (Angel Dust)IBA
12/2002
1N-Methylaspartate (NMDA)IBA
12/2002

Therapy/Procedure

1Drug Therapy (Chemotherapy)
01/2008